SOM Innovation Biotech, SA Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2009

Location

Barcelona Spain

Primary Industry

Biotechnology

About

Founded in 2009 by Raúl Insa (President/CEO), and based in Barcelona, Spain, SOM Innovation Biotech, SA is a biotechnology company that develops and repurposes drugs for addressing diseases of the central nervous system. In December 2023, the firm raised USD 17 million in series B funding from EIB and the Prevail Partner Fund. SOM Innovation Biotech, SA’s partners include Clinic Barcelona, Duchenne Parent Project, Corino Therapeutics, U-Cell Therapeutics, etc. The company uses artificial intelligence to discover new indications for existing drugs, reducing the risk of clinical development for diseases like TTR Amyloidosis, Huntington's disease, Tardive dyskinesia, Adrenoleukodystrophy, Adrenomyeloneuropathy, Phenylketonuria, and Niemann-Pick disease. To help reduce drug development costs and development time, the company offers drug repurposing activities that focus on diseases with little or no available medication. SOM Innovation Biotech, SA plans to use the December 2023 funding to further enhance its product offering.

Current Investors

European Investment Bank, Prevail Partners

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.sombiotech.com

Verticals

Artificial Intelligence

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.